2Seventy Bio Inc reports results for the quarter ended in December - Earnings Summary

2Seventy Bio

05/03/2024 23:42

* 2Seventy Bio Inc  TSVT.OQ  reported a quarterly adjusted
loss of
$1.11​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -60
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 99 cents per share. Wall Street expected
results to range from $-1.37 to -68 cents per share.
    * Revenue fell 81% to $10.68 million from a year ago;
analysts
expected $14.71 million. 
    * 2Seventy Bio Inc's reported EPS for the quarter was a loss
of
$1.11​.
    * The company reported a quarterly loss of $56.82 million.
    * 2Seventy Bio Inc shares had risen by 26.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for 2Seventy Bio Inc
is $8.00 
This summary was machine generated from LSEG data March 5 at
11:41 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.99          -1.11          Missed
 Sep. 30 2023      -1.03          -1.00          Beat
 Jun. 30 2023      -1.06          -0.83          Beat
 Mar. 31 2023      -1.19          -1.08          Beat